Premium
[O1–05–01]: CLINICAL VALIDATION OF DIAGNOSING ALZHEIMER's DISEASE BY ASSAYING PLASMA AMYLOIDS AND TAU PROTEIN VIA IMMUNOMAGNETIC REDUCTION
Author(s) -
Yang ShiehYueh,
Chiu MingJang,
Chen TaFu,
Hu ChaurJong,
Yan SuiHing,
Sun Yu,
Liu BingHsien,
Yang CheChuan
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.07.058
Subject(s) - cohort , medicine , tau protein , amyloid beta , amyloid (mycology) , alzheimer's disease , biomarker , cohort study , disease , area under the curve , guideline , gastroenterology , oncology , pathology , chemistry , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom